Why does the NHS struggle to adopt eHealth innovations? A review of macro, meso and micro factors by Asthana, S et al.
BMC Health Services Research
 
Why does the NHS struggle to adopt eHealth innovations? A review of macro, meso
and micro factors
--Manuscript Draft--
 
Manuscript Number: BHSR-D-19-00499R2
Full Title: Why does the NHS struggle to adopt eHealth innovations? A review of macro, meso
and micro factors
Article Type: Debate
Section/Category: Health policy, reform, governance and law
Funding Information: European Regional Development Fund
(05R16P00385)
Professor Ray Jones
Abstract: n/a
Corresponding Author: Sheena Asthana, BA (Oxon) PhD
University of Plymouth
UNITED KINGDOM
Corresponding Author E-Mail: S.Asthana@plymouth.ac.uk
Corresponding Author Secondary
Information:
Corresponding Author's Institution: University of Plymouth
Corresponding Author's Secondary
Institution:
First Author: Sheena Asthana, BA (Oxon) PhD
First Author Secondary Information:
Order of Authors: Sheena Asthana, BA (Oxon) PhD
Ray Jones, BSc, MSc, PhD
Rod Sheaff, BA (Oxon), DPhil
Order of Authors Secondary Information:
Response to Reviewers: Thank you for accepting the manuscript subject to minor revisions. I have made all of
the changes requested (including removing three authors who, according to your
guidelines, did not make a contribution to the article). I note that, on conversion, line
numbers reappear in the manuscript. I did try to provide a final, clean copy but can't
seem to stop this from happening!
Don't hesitate to get back if I have overlooked anything.
Additional Information:
Question Response
Has this manuscript been submitted
before to this journal or another journal in
the <a
href="https://www.biomedcentral.com/p/th
e-bmc-series-journals#journallist"
target="_blank" >BMC series</ a>?
No
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
1 
 
Why does the NHS struggle to adopt eHealth innovations? A review of 
macro, meso and micro factors 
 
Sheena Asthana, (BA (Oxon), PhD), Professor of Health Policy, School of Law, Criminology and 
Government, University of Plymouth, S.Asthana@plymouth.ac.uk 
Ray Jones (BSc, MSc, PhD), Professor of Health Informatics. School of Nursing and Midwifery, 
University of Plymouth, ray.jones@plymouth.ac.uk 
Rod Sheaff (BA (Oxon), DPhil), Professor of Health Services Research, School of Law, 
Criminology and Government, University of Plymouth, rod.sheaff@plymouth.ac.uk 
 
Corresponding author: Sheena Asthana  
Manuscript Click here to access/download;Manuscript;ASTHANA BMC
HSR revised Oct 4.docx
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2 
 
Why does the NHS struggle to adopt eHealth innovations? A review of 
macro, meso and micro factors 
 
Abstract 
Background: Having a tax-funded and supposedly ‘National’ Health Service (NHS), one 
might assume that the UK is well-positioned to roll out eHealth innovations at scale. Yet, 
despite a strong policy push, the English NHS has been limited in the extent to which it has 
exploited the potential of eHealth.  
Main body: This paper considers a range of macro, meso and micro factors influencing 
eHealth innovation in the English NHS.  
Conclusions: While barriers to eHealth innovation exist at all scales, the fragmentation of the 
NHS is the most significant factor limiting adoption and diffusion. Rather than addressing 
problems of fragmentation, national policy seems to have intensified the digital divide. As the 
recently published NHS Long Term Plan places great emphasis on the role of digital 
transformation in helping health and care professionals communicate better and enabling 
people to access the care they need quickly and easily, the implications for the digital divide 
are likely to be significant for effectiveness, efficiency and equity. 
Keywords: eHealth, innovation, NHS, digital policy, barriers to eHealth  
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Background 
Developing a healthcare delivery system that is more responsive to the future challenges of an 
ageing population is a priority in most higher income countries experiencing late demographic 
and epidemiological transition. The United Kingdom (UK) is no exception. In mid-2014, the 
average age in the UK exceeded 40 for the first time. By 2040, nearly one in seven people is 
projected to be aged over 75, a trend that is likely to be accompanied by an increase in the 
prevalence of chronic conditions, multi-morbidities, cognitive impairments and long-term 
frailty1.  
The UK Government expects technology to play an increasingly important role in providing 
health and care support for its ageing population. The previous health and social care Secretary 
of State identified the need for the full integration of the health and social care system and for 
the National Health Service (NHS) to become “massively more teched up”2. His successor has 
listed technology as one of his top three priorities, believing that this could help achieve 
improvements in the other two – workforce and the prevention of illness. Their ambitions come 
after a series of parliamentary and government reports (most notably the recent NHS Long 
Term Plan3) that have called for the NHS to incorporate more health and medical technologies4-
7. Yet, ten years after Lord Darzi wrote in a national review of the NHS that “(i)n this country, 
we have a proud record of invention, but we lag behind in systematic uptake even of our own 
inventions”8, the idea that the UK is great at generating innovations but poor at adopting them 
remains received wisdom. 
The aim of this paper is to consider why, given such a very strong policy push, the NHS still 
struggles to adopt eHealth innovations. We present macro, meso and micro factors affecting 
innovation in eHealth, which not only act as barriers to companies seeking to commercialise 
and scale up their digital health businesses in the UK. Evidence of a growing digital divide 
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between different geographical areas raises questions about the equity implications of the 
failure to ‘tech up’. 
What do we mean by ‘eHealth’ 
As there are European Union (EU) Regulations for medical devices and in vitro diagnostic 
medical devices as well as clear guidelines describing how the National Institute for Health 
and Clinical Excellence (NICE) evaluates and recommends technologies selected for appraisal, 
such products have a clear route to market readiness (though not necessarily to their adoption). 
Against this background, this paper focuses on the less specific area of eHealth.  
Since earlier definitions9-12, more recent attempts to scope digital health innovation ecosystems 
illustrate the growing breadth of eHealth13-15. This simple term can encapsulate e-health, m-
health (sometimes viewed as a subset of eHealth), medicine 2.0, telemedicine and telecare, 
public health surveillance, personalized medicine/patient engagement, health and medical 
platforms, self-tracking (the quantified self), wireless health and sensors, medical imaging, 
healthcare information systems, mobile connectivity, social networking, sensors and 
wearables, gamification, electronic health records, big data, health information technology, 
health analytics, and digitized health systems. We would take a broader view still and include 
digital devices, robotics, and active assistive living16. 
A mixed performance 
With the value of the global market in mobile health alone reaching an estimated $25 billion 
in 201717, eHealth is big business. According to analysis by Monitor Deloitte18, the mHealth 
market (for health-related apps and wearable devices) is small and fragmented in the UK, 
accounting for a relatively low proportion of the global market. Data on consumer use of 
eHealth services is mixed, people in the UK being less likely to have used health apps than 
those in France and Italy, but more likely than in Austria and Germany. However, this is 
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primarily to help maintain a healthy lifestyle, Britons being less likely to use health apps to 
manage a health condition, store personal medical data or contact a health professional than 
people in the other countries surveyed, suggesting less integration with formal health 
services19.  
The UK was an early adopter of information and communications technology (ICT) in primary 
care, scoring relatively well among EU member states with respect to the use of computers in 
General Practice20,21. However, rates of electronic prescribing are now lower than in Nordic 
countries. There is, moreover, significant variation between Local Pharmaceutical Committees, 
the percentage of e-repeat prescriptions ranging from 45% to 13% in April 201922.) The area 
where the UK has particularly fallen behind is in digital health systems and eHealth 
interoperability. While hospitals departments may have good specialist IT, many hospitals in 
England still lack comprehensive electronic patient record (EPR) systems23 and the 
digitalisation of community health services is even further behind. This has had consequences 
for the sharing of information across different providers and the coordination of care. 
The UK is not alone in developing national strategies or policies for eHealth, nor in 
encountering problems in establishing its eHealth systems. For example, the World Health 
Organisation WHO) recognises that progress in adopting eHealth has not been uniform across 
all countries in the European Region. It also notes that success in national eHealth adoption is 
often influenced by a range of factors that extend beyond the obvious requirements of skills 
and funding for technology and suggests that intersectoral engagement of stakeholders, led by 
the health ministry, is a key catalyst for success24. 
Having a tax-funded and supposedly ‘National’ Health Service, one might assume that the UK 
is well-positioned to take a lead in rolling out eHealth innovations at scale. However, the UK 
health market is significantly more complex than is often appreciated outside the system. First, 
the devolution of the NHS has resulted in significant differences in the health systems of the 
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home countries of the UK25. Thus, the National Health Services of Scotland, Wales and 
Northern Ireland are very different to the NHS in England. Second, the English NHS is 
characterised by a mixture of centralisation with respect to policy setting, regulation 
frameworks and information governance but considerable fragmentation with respect to the 
organisation and delivery of care. This makes it a complex landscape for eHealth companies 
seeking to enter the system and scale up innovation. 
Macro scale factors influencing the adoption of eHealth innovations in the NHS 
At the macro-scale, the English institutional context is ostensibly supportive of technological 
innovation, not least because of an interest in its scope to improve efficiency and productivity 
in a system that is experiencing severe financial pressures. With reported deficits in provider 
trusts hitting around £1 billion and an additional £213 million over-spend in commissioning 
organisations26, the English NHS is increasingly described as being in a state of ‘crisis’27. The 
last four winters (2015-18) have certainly seen numerous hospital trusts declare ‘black alerts’ 
about their ability to meet patient demand, with associated delays in pre-planned operations 
and routine outpatient appointments. There are also worrying trends in staff recruitment, 
retention and morale; and performance against key indicators (e.g. waiting times in Accident 
and Emergency and for referrals, including for cancer) appears to have worsened27. 
The current health and social care Secretary of State believes that the transformation of 
technology is key to releasing staff time from unnecessary bureaucracy and ensuring that 
different parts of the system communicate better. His pledge to invest almost half a billion 
pounds ($650m) in NHS technology28 follows several policy schemes and investments relating 
to innovation. Against a supportive policy context, however, there remain important structural 
barriers to the adoption and diffusion of eHealth innovations (see below). 
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A supportive policy context 
Since the publication of the Wachter review of health technology29, there has been a plethora 
of initiatives designed to speed up the adoption of innovative new drugs, devices, diagnostics 
and digital products in the NHS. The government’s Accelerated Access Review6, published in 
2016, introduced a newly planned Accelerated Access Pathway to prioritise strategically 
important innovations, an Innovation and Technology Payment to reimburse providers for a 
small number of selected innovations and more funding for Academic Health Science 
Networks to enhance local routes to market. In the same year, the Secretary of State announced 
a £4 billion ($5.2bn) fund to enable the NHS to be ‘paperless’ at the point of care by 2018 (this 
has not happened) and to be using digital, interoperable health and social care records by 2020 
(this is unlikely to happen). More recently, the Office for Life Sciences launched a £35m 
($46m) Digital Health Technology Catalyst Fund for Small and Medium Enterprises (SMEs) 
working in health technology. The most digitally advanced Trusts (16 acute, 7 mental health 
and 3 ambulance trusts) have been awarded Global Digital Exemplar (GDE) status and given 
matched funding of £10m each for their digital projects; a further £200m ($260m) is being 
invested to help trusts get new IT systems off the ground; and the government is piloting a new 
NHS app to allow patients to book appointments and access their general practice (GP) record. 
Digitisation and interoperability 
Despite these positive policy developments, the NHS lags behind countries such as the US, 
with respect to basic digitisation and interoperability30. One possible factor may be the role that 
processing insurance claims has played in creating a demand for the development of electronic 
health records in the United States and social health insurance systems in Western Europe. 
Payment systems are different in the NHS, funding being distributed to the commissioners of 
health services (Clinical Commissioning Groups) through a central formula, while most 
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hospital services are paid for using national tariffs. Developing standardised electronic patient 
record systems has not been a requirement for NHS transactions. 
General practice is one area where the delivery of evidence-based clinical interventions attracts 
additional financial (Quality and Outcomes Framework) resources and it may be no 
coincidence that general practice in England is now virtually entirely digitised (though 
practices use several, nationally available electronic record systems, which are not standardised 
and not linked to other electronic health systems). By contrast, many English health and social 
care providers are still operating with paper records. Based on census-level data of technology 
adoption by English NHS hospitals, Digital Health Intelligence suggests that all NHS hospitals 
will not be paperless until 2027 at the earliest31. Progress in digitising community health and 
social care records has been even slower. The Department of Health and Social Care appears 
to have at least recognised the problem, with recent announcements that digitally less mature 
areas will receive central funding. It is too early to comment on what this will mean in practice. 
A lack of digitisation clearly limits the ability of providers to e.g. effectively share information 
between patients, professionals, care settings and organisations, as does the fact that the NHS 
contains a plethora of incompatible patient record systems that have developed to meet the 
needs of local services or specialties. Following the disastrous National Programme for IT24,32 
launched in 2002 and dismantled in 2011 after an investment of £7.3bn ($9.5bn), the NHS 
moved away from the idea of top-down mandated IT systems and instead encouraged a ‘let 
many flowers bloom’ approach. Local diversity is still encouraged, but, with the introduction 
of mandated standards for interoperability, privacy and cyber security, a “middle-out” approach 
is now being pursued that combines government direction with increased local autonomy33. 
Many agree that there is more hope for a genuine bottom-up change model, freed from the 
fetters of heavy-handed state control34,35. Yet, in the absence of a clearer national steer, many 
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commissioners lack confidence in procuring new digital systems and technologies (see below). 
The ‘let many flowers bloom’ philosophy is also confusing for technology suppliers.  
Regulation and accreditation 
One of the challenges facing those responsible for the planning and commissioning of NHS 
services for their local area is that that they are expected to draw upon robust evidence of e.g. 
quality, safety and cost-effectiveness to inform commissioning decisions. Despite a 
proliferation of eHealth technologies, few meet these evidential requirements. For example, 
NHS Digital (a division of the NHS) is the lead national delivery partner for improving the use 
of data and digital technologies in the health and care system. Yet, its Apps Library currently 
showcases 74 apps, a fraction of the 50,000 medical apps that are available in the Apple App 
Store worldwide. 
This lack of evidence probably says more about methodology and existing regulatory standards 
than the effectiveness of eHealth innovations themselves36. Large pharmaceutical companies 
have become adept at producing cost-effectiveness analyses for the technical appraisal and 
licencing of pharmaceutical products, however questionable the methods and findings may 
sometimes be37,38. Producers of medical devices are also given clear guidance about evidential 
requirements for technological appraisals undertaken by the National Institute for Health and 
Care Excellence (NICE). By contrast, the eHealth sector is dominated by small and medium 
sized enterprises (SMEs) many of which do not have the capacity to address the technical, 
clinical or cost-effectiveness standards required by NHS Digital and NICE.  
For example, NHS Digital’s Digital Assessment Questionnaire comprises 12 domains and 
several hundred questions which, in addition to covering more technical issues such as data 
protection, security and interoperability, explore issues that imply a degree of evaluation, such 
as effectiveness, clinical safety, usability and accessibility. NICE presides over the indicators 
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of effectiveness questions and, in its own appraisals of e.g. Improving Access to Psychological 
Therapies apps, tends to expect Randomised Control Trial level evidence. Thus, in the most 
recent evidence standards framework for digital health technologies39, high quality 
observational or quasi-experimental studies demonstrating relevant outcomes are described as 
the minimum practice standard for demonstrating effectiveness. High quality intervention 
studies (quasi-experimental or experimental design) which incorporate a comparison group are 
considered the best practice standard.  
It is questionable whether these expectations are proportionate to the needs of SMEs. Thus, 
those that do achieve wider roll-out tend to do so without appropriate evaluation. In July 2018, 
the Lancet published an editorial, calling for a clearer assessment framework in the UK for 
digital health, “to differentiate efficacious digital products from commercial opportunism”40. 
Insofar as a distinction is now being made between best practice and minimum evidence 
standards, the challenges of using traditional methods to judge the effectiveness of eHealth 
interventions are being acknowledged. We await clear guidance as to whether and how this 
translates into advice on proportionate methods of demonstrating the usability, clinical 
effectiveness, impact on softer outcomes etc. of eHealth technologies. 
The Lancet’s reservations may have been fuelled by the rapid adoption in 2018 of Babylon 
Health, a health service provider that provides remote consultations with doctors and health 
care professionals via text and video messaging through its mobile application. The service 
requires a subscription fee, something many consider an affront to the NHS’s commitment to 
provide access to health care free at the point of use. Babylon’s symptom-checking chatbot has 
also attracted criticism for apparent inaccuracies in diagnosis. So far, NHS Digital has neither 
approved nor much influenced invention and adoption of this app.  Questions have thus been 
raised as to whether national regulatory and indeed procurement and reimbursement systems 
are sufficiently agile and proportionate to support adoption at scale41,42. The UK is in a strange 
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place with, on the one hand, tight regulation of its NHS providers and, on the other, an open 
private market for digital providers.  
Meso scale factors influencing the adoption of eHealth innovations in the NHS 
At the meso (commissioner and provider organisation) scale, important roles are played by the 
organisational conditions and capabilities of adopters43-44. These range enormously in England, 
a highly fragmented healthcare system which has more than 200 Clinical Commissioning 
Groups (CCGs), nearly 200 provider trusts, more than 7500 primary care practices and a 
structural separation between the NHS (and within it, between general medical practice and 
community health services) and social care. This not only creates a confusing myriad of entry 
points for entrepreneurs and industry45. It has led to significant geographical variation in digital 
readiness, infrastructure, competencies regarding procurement and so on.  
Financial pressures are also differentially distributed in the NHS and can lead to a lack of 
money to support innovation. Clinical Commissioning Groups (CCGs) serving older 
populations in rural areas are significantly more likely to be in deficit than their metropolitan 
counterparts, as are provider Trusts in coastal areas and rural shires46. There are concerns that 
financially struggling organisations are more likely to value the potential of eHealth 
innovations in narrow cost-savings terms - which are not usually easy to evidence - and to place 
less value on innovations that could potentially transform the quality of care. There is also a 
tendency to be risk averse with respect to investing in new initiatives unless they are nationally 
accredited or endorsed. 
National policy, particularly the decision to invest in Trusts that are already digitally advanced, 
has exacerbated the digital divide. Recognising that there was insufficient funding to achieve 
the vision of a paperless NHS, leaders of the NHS IT Strategy chose to invest in a relatively 
small group of digitally advanced providers with a view to demonstrating what investment in 
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NHS IT could achieve. Areas that have shown potential to go on and develop shared health and 
care records for the people in their wider region have been awarded Local Health and Care 
Record Exemplar (LHCRE) status47. Future investment of £37.5m ($50m) in new Digital 
Innovation Hubs which is designed to connect regional health and care data with biomedical 
data is expected to complement initiatives such as LHCRE. Areas such as Greater Manchester 
are now galloping ahead with respect to their digital health ecosystems and, as such, are 
attracting further investment from both Government and industry. As a result, digital maturity 
would appear to be geographically concentrating rather than trickling down. 
Micro scale factors influencing the adoption of eHealth innovations in the NHS 
At the micro-scale, new technologies need to fit values, priorities and routines – of staff and 
patients48. Resistance to technological innovation may be based on legitimate concerns that it 
will lead to ‘hidden work’49 or undermine the quality of patient-professional interactions. 
Several studies suggest that, far from being convenient, Electronic Health Records can be 
highly labour intensive with respect to data entry. This needs to be understood within the 
context of the high regulatory, bureaucratic and administrative burden of the NHS, the level of 
data required by the system colloquially referred to as ‘feeding the beast’. Tensions between 
the NHS’s Information Governance framework (e.g. around patient confidentiality) and the 
potential benefits of e.g. record sharing can also be difficult to negotiate. Finally, there is 
uncertainty as to how technological developments (e.g. genomics, digital medicine, artificial 
intelligence (AI) and robotics) will change the roles and functions of clinical staff, which 
naturally gives rise to scepticism. Greenhalgh et al41 suggest that acceptance by professional 
staff may be the single most important determinant of whether a new technology-supported 
service succeeds or fails at a local level.  
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Interpersonal connections are also critical for creating the necessary trust in innovation50. Yet, 
the health and social care system in England has been characterised as one that is rich in isolated 
clusters in need of connectivity51. At very localised levels, there are many examples of 
innovations being championed by local clinicians in the NHS. However, wider roll-out requires 
opportunities for interactions between clinicians, commissioners and other health and care 
professionals, technology developers and patients as well as their respective networks44,52. Too 
often, senior NHS managers and health care professionals seem to be rather suspicious of 
SMEs’ motives, preferring to e.g. hold on to (subsequently undeveloped) intellectual property 
rather than work in partnership with businesses. 
Such barriers are recognised within the NHS (indeed, ‘cultural’ barriers to innovation are more 
likely to be highlighted in policy documents than structural issues relating to fragmentation and 
underfunding). For example, the recent Topol Review53 highlights the need to appoint “clinical 
informatics translators” who can support leadership through chief clinical information officers 
and other clinical informatics professionals, and to develop broad expertise in informatics 
across all healthcare professionals. Cultural barriers to inter-organisational and inter-
professional working will still need to be addressed, however.  
Conclusion 
In this paper we have explored the apparent paradox that the NHS, a system that is often 
perceived to be a single, monolithic organisation, does not respond well to central policy 
directives such as those calling for technology to play an increasingly important role in 
providing health and care. Of the macro, meso and micro factors we have presented, we propose 
that the fragmentation of the NHS is the most important barrier to innovation, a problem that 
is exacerbated by current approaches to appraisal that are not sufficiently agile for rapidly 
evolving technologies or proportionate for SMEs. As a result, we have a proliferation of 
eHealth technologies at the local level, very few of which are formally evaluated and more 
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widely marketed. This leads to localisation in roll-out, inequalities in access and replication of 
investment in different local areas. Variations in the digital health systems used between and 
within local areas are also unhelpful, not least because of the additional resources this demands 
of companies (e.g. who may have to pay for several application programming interfaces (APIs) 
for an identical product). Rather than addressing problems of fragmentation, national policy 
seems to be intensifying the digital divide. Companies seeking to exploit the UK’s unrealised 
potential with respect to digital health will find good opportunities to engage and gain traction 
in Greater Manchester and London and the South East. Outside these areas, the market remains 
precarious.  
As the NHS Long Term Plan places great emphasis on the role of digital transformation in 
helping health and care professionals communicate better and enabling people to access the 
care they need quickly and easily, the implications for the digital divide are likely to be 
significant for effectiveness, efficiency and equity. Cross-national studies suggest that the 
scope of e-Health implementation mostly depends on political as opposed to economic and 
health-related factors54, we would propose the need for a very strong central steer to address 
the deeply embedded barriers to innovation in the NHS.  
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